Affiliation:
1. Department of Pathology, Osaka City University Medical School.
Abstract
BACKGROUND
Restenosis after initial, successful percutaneous transluminal coronary angioplasty (PTCA) is due to fibrocellular proliferation.
METHODS AND RESULTS
The present study focused on the nature of fibrocellular tissue in humans by use of immunocytochemical techniques. Four hearts (five coronary arteries) were investigated; time lapse between PTCA and death varied between 20 days (two arteries) and 1 year 7 months. Proliferating cells stained positive with smooth muscle cell-specific monoclonal antibodies. Cells from early proliferative lesions (20 days) have a phenotypic expression different from cells in "old" lesions. Proliferating cells stained positive with vimentin but were negative with desmin, irrespective of the lesion's age.
CONCLUSIONS
The findings indicate a change in actin isoform expression of smooth muscle cells while adapting to a pathological state.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference22 articles.
1. Transluminal coronary angioplasty and early restenosis. Fibrocellular occlusion after wall laceration.
2. Ultrastructural study of proliferating and migrating smooth muscle cells at the site of PTCA as an explanation for restenosis (abstract);Ohara T;Circulation,1988
3. Histopathologic phenomena at the site of percutaneous transluminal coronary angioplasty: The problem of restenosis
4. A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes.
5. Human atherosclerosis: II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions;Gown AM;Am J Pathol,1986
Cited by
108 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献